Evaluation of the Vitros® Anti-T. cruzi assay for its incorporation into the Trypanosoma cruzi infection diagnostic algorithm
The Vitros® Anti-T. cruzi assay showed potential for implementation as an automated serological screening test, enhancing the diagnostic process in high-throughput microbiology laboratories.
Authors
- Père-Joan Cardona (ORCID: https://orcid.org/0000-0001-5623-7873)
- Nandy López (ORCID: https://orcid.org/0000-0002-2929-5645)
- Miriam Campos-Ruiz (ORCID: https://orcid.org/0000-0002-4454-4267)
- Gema Fernández‐Rivas (ORCID: https://orcid.org/0000-0003-4854-5934)
- Victoria González (ORCID: https://orcid.org/0000-0003-3787-0272)
- Belén Rivaya (ORCID: https://orcid.org/0000-0003-2562-6248)
- Beatriz Rodríguez-Ponga (ORCID: https://orcid.org/0000-0003-1386-2366)
- Jun Hao Wang-Wang (ORCID: https://orcid.org/0000-0003-2609-6453)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Generalitat de Catalunya (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
Publication Details
- Journal
- Heliyon
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e40673
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00